Marina Bue - MolMed S Insider

4HW -- Germany Stock  

EUR 0.33  0.008  2.40%

  Director
Dr. Marina Del Bue serves as General Manager of Business Development and Administration Executive Director of Molecular Medicine S.p.A. since January 31 2011. She was General Manager since November 2000 and was in the Company Board since November 6 2007. She has over 25 years of experience in the economic management of research and development within the pharmaceutical industry. From 1981 to 1986 she conducted research for the biotechnology division of Eni Ricerche. She joined Gruppo Menarini in 1990 and gained experience as Controller of the Research and Development Division until 2000. She is Member of the Management Committee of the Cure Committee of the Healthcare Council of EuropaBio a European bio industry organization as well as Vice Chairman of Assobiotec an Italian organization for the development of biotechnology. She gained a BS in Biological Sciences from the Universita degli Studi di Roma Sapienza and obtained a Masters of Business Administration from Universita Commerciale Luigi Bocconi.
Age: 56  Director Since 2011      
39 02 21 27 71  http://www.molmed.com

Management Efficiency

The company has return on total asset (ROA) of (11.32) % which means that it has lost $11.32 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (25.93) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 964 K in total debt with debt to equity ratio (D/E) of 3.9 implying the company greatly relies on financing operations through barroing. MolMed S p A has Current Ratio of 1.94 which is within standard range for the sector.

Similar Executives

Entity Summary

MolMed S.p.A., a medical biotechnology company, focuses on the research, development, and clinical validation of anticancer therapies. MolMed S.p.A. was founded in 1996 and is headquartered in Milan, Italy. MolMed S operates under Biotechnology classification in Germany and traded on Frankfurt Stock Exchange.MolMed S p A (4HW) is traded on Frankfurt Stock Exchange in Germany. It is located in Via Olgettina, 58 and employs 23 people.

MolMed S p Leadership Team

Gian Rizzardi, Director Research & Development
Marina Bue, General Manager of Business Development and Administration, Executive Director
Didier Trono, Independent Director
Silvia Pisante, Head of Legal Affairs & Corporate Governance
Mario Masciocchi, Lead Independent Director
Carlo Incerti, Independent Director
Ilaria Candotti, Investor Relations & Communication Manager
Raffaella Ruggiero, Independent Director
Holger Neecke, Director Business Development & Investor Relations
Luca Alberici, Head of Business Development
Maurizio Tassi, Non-Executive Director
Daniele Pieraccioli, Director Intellectual Property
Salvatore Calabrese, CFO
Alberto Carletti, Non-Executive Director
Laura Ferro, Independent Director
Marco Dieci, Director Special Projects
Catia Traversari, Director Research
Lorenzo Salieri, Director
Elizabeth Robinson, Independent Director
Giuliana Vallanti, Director of Development, Quality Control and Qualified Person
Riccardo Palmisano, CEO
Sabina Grossi, Non-Executive Director
Alfredo Messina, Non-Executive Director
Simona Rovetta, Operations Director
Monica Masolo, Independent Director
Germano Carganico, General Manager of Research & Development and Operations
Claudio Bordignon, Chairman of the Board, CEO
Gianluigi Fiorendi, Non-Independent Non-Executive Director
Andrea Quaglino, Director Administration Finance & Control
Khalid Islam, Non-Executive Non-Independent Director
Laura Villa, Director of Investor Relations & Communication
Cynthia Giuliani, Director of Human Resources
Antonio Lambiase, Director Clinical Development
Marco Manoni, Director Operations
Tiziano Andreoli, Director of Information Technology

Stock Performance Indicators

Current Sentiment - 4HW

MolMed S p Investor Sentiment

Macroaxis portfolio users are unresponsive in their sentiment towards investing in MolMed S p A. What is your trading attitude regarding investing in MolMed S p A? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  
Check also Trending Equities. Please also try Bollinger Bands module to use bollinger bands indicator to analyze target price for a given investing horizon.
Search macroaxis.com